Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
53 studies found for:    Antiphospholipid Syndrome
Show Display Options
Rank Status Study
21 Unknown  Preconceptional Thromboprophylaxis in Recurrent PREGNANCY LOSSES Caused by Antiphospholipid Syndrome
Conditions: Recurrent Pregnancy Losses;   Positive Anti Phospholipid Syndrome
Intervention: Drug: low molecular weight heparin (enoxeparine)
22 Completed Assessment of the Prevalence of Major Psychiatric Disorders in a Cohort of Women With Clinical Criteria Corresponding to Pure, Abortive-form, Obstetrical, Antiphospholipid Syndrome
Conditions: Antiphospholipid Syndrome;   Factor V Leiden Thrombophilia
23 Active, not recruiting Eculizumab to Enable Renal Transplantation in Patients With History of Catastrophic Antiphospholipid Antibody Syndrome
Conditions: Antiphospholipid Antibody Syndrome;   End Stage Renal Disease
Intervention: Drug: Eculizumab
24 Completed The Prognostic Value of PGF and sFlt1 Variations Induced by the First Low-molecular-weight-heparin Injections in Women With Obstetrical Antiphospholipids Antibody Syndrome Starting a New Pregnancy and Following Treatment in Accordance With International Recommendations
Condition: Antiphospholipid Syndrome
25 Completed CoaguChek XS in Antiphospholipid Antibody Syndrome (APL) Patients
Condition: Antiphospholipid Antibody Syndrome
Interventions: Device: CoaguChek XS;   Procedure: Standard Lab Draw
26 Completed Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody Syndrome
Conditions: Systemic Lupus Erythematosus;   Antiphospholipid Antibody Syndrome
Interventions: Drug: Cyclophosphamide;   Drug: filgrastim
27 Unknown  Steroids and Antiphospholipid Syndrome- Related Pregnancy Loss
Condition: Antiphospholipid Syndrome
Intervention: Drug: Low dose steroids
28 Completed Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome
Condition: Antiphospholipid (aPL)-Positive
Intervention: Biological: Study Drug- ALXN1007
29 Unknown  The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic Syndrome
Conditions: Antiphospholipid Syndrome;   Endothelial Dysfunction;   Hyperuricemia;   Gout;   Metabolic Syndrome
30 Not yet recruiting Antiphospholipid Antibodies and Early Severe Preeclampsia.
Conditions: Severe Preeclampsia;   Antiphospholipid Syndrome
31 Not yet recruiting Antiphospholipid Antibodies and Fetal Growth Restriction
Conditions: Fetal Growth Restriction;   Antiphospholipid Syndrome
32 Unknown  Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE)
Conditions: Antiphospholipid Syndrome;   Thrombophilia Due to Antiphospholipid Antibody;   Systemic Lupus Erythematosus
Intervention: Other: Phlebotomy
33 Completed Hypercoagulable Phenotype by Thrombinography (in Presence of C Protein Dynamic Inhibitory System)
Condition: Venous Thrombosis
Intervention: Other: Blood sample
34 Recruiting Pregnancy and Medically Assisted Conception in Rare Diseases
Conditions: Rheumatoid Arthritis;   Spondyloarthritis;   Psoriatic Arthritis;   Systemic Lupus Erythematosus;   Antiphospholipid Syndrome;   Sjogren Syndrome;   Scleroderma;   Myositis;   Vasculitis;   Mastocytosis;   Various Autoimmune and/or Systemic and/or Rare Diseases
35 Unknown  Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases
Conditions: Rheumatoid Arthritis;   Spondyloarthritis;   Systemic Lupus Erythematosus (SLE);   Dermatomyositis (DM);   DMixed Connective Tissue Disease;   Systemic Vasculitis;   Systemic Sclerosis (SSc);   Sjögren's Syndrome;   Antiphospholipid Syndrome;   Juvenile Idiopathic Arthritis;   Juvenile SLE;   Juvenile DM
Intervention: Biological: Anti-pandemic H1N1 influenza vaccine
36 Completed CI(R)CA : Coumadin Interaction With Rofecoxib, Celecoxib and Acetaminophen
Condition: Antiphospholipid Antibody Syndrome
Interventions: Drug: Celecoxib;   Drug: Acetaminophen;   Drug: Rofecoxib;   Drug: placebo
37 Recruiting Phenomics in Autoimmune and Inflammatory Diseases
Conditions: Healthy Volunteer;   Rheumatoid Arthritis;   Ankylosing Spondylitis;   Systemic Lupus Erythematosus/Antiphospholipid Syndrome;   FMF;   Cryopyrin-Associated Periodic Syndromes /TNF-receptor Associated Periodic Syndrome;   Vasculitis;   Uveitis;   Myositis;   Crohn's Disease;   Ulcerative Rectocolitis;   Type 1 Diabetes;   Unclassified IAD Knee and/or Hip Arthritis, Muscular Dystrophy
Interventions: Other: 1: AID groups;   Other: 2: Control groups
38 Unknown  Longitudinal Study of the Clinical and Haematological Cause of Women With Antiphospholipid Antibodies.
Condition: Antiphospholipid Syndrome
39 Terminated Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients
Condition: Antiphospholipid Syndrome
Intervention: Drug: Hydroxychloroquine
40 Completed Pharmacogenetics of Warfarin in Puerto Ricans.
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Cardiac Valvular Insufficiency;   Antiphospholipid Syndrome;   Coagulopathy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-53) Show next page of results    Last Page
Indicates status has not been verified in more than two years